Activation of K+ channels: An essential pathway in programmed cell death

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 1 30-1, 2004, Pages

  Remillard, Carmelle V ^a   Yuan, Jason X J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cell volume regulation; Ion channels; Pulmonary artery smooth muscle cells; Pulmonary hypertension

Indexed keywords

CASPASE; DNA FRAGMENT; POTASSIUM CHANNEL;

APOPTOSIS; CELL MEMBRANE TRANSPORT; CELL PROLIFERATION; CELL STRUCTURE; CELL VOLUME; DNA DEGRADATION; ENZYME ACTIVATION; HEMOSTASIS; HYPERTROPHY; ION TRANSPORT; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; PHAGOCYTOSIS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVIEW; TUMOR GROWTH;

EID: 0346727499     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00041.2003     Document Type: Review

References (197)

1. Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
2. Adrain C, Creagh EM, and Martin SJ. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20: 6627-6636, 2001.
3. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, and Weissman IL. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033-1041, 1997.
4. Allbritton NL, Verret CR, Wolley RC, and Eisen HN. Calcium ion concentrations and DNA fragmentation in target cell destruction by murine cloned cytotoxic T lymphocytes. J Exp Med 167: 514-527, 1988.
5. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod J-J, Mazzei G, Maundrell K, Gambale F, Sadoul R, and Martinou J-C. Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372, 1997.
6. Archer S and Rich S. Primary pulmonary hypertension: a vascular biology and translational research "work in progress". Circulation 102: 2781-2791, 2000.
7. Archer SL, London B, Hampl V, We X, Nsair A, Puttagunta L, Hashimoto K, Waite RE, and Michelakis E. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J 15: 1801-1803, 2001.
8. + channels, Kv1.5 and Kv1.2, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 101: 2319-2330, 1998.
9. Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, and Morrell NW. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105: 1672-1678, 2002.
10. Bal-Price A, Borutaite V, and Brown GC. Mitochondria mediate nitric oxide-induced cell death. Ann NY Acad Sci 893: 376-378, 1999.
11. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 12: 735-773, 1994.
12. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79: 1127-1155, 1999.
13. Bock J, Szabó I, Jekle A, and Gulbins E. Actinomycin D-induced apoptosis involves the potassium channel Kv1.3. Biochem Biophys Res Commun 295: 526-531, 2002.
14. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, and Thompson CB. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98, 1995.
15. Bortner CD and Cidlowski JA. Absence of volume regulatory mechanisms contributes to the rapid activation of apoptosis in thymocytes. Am J Physiol Cell Physiol 271: C950-C961, 1996.
16. Bortner CD and Cidlowski JA. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 56: 1549-1559, 1998.
17. Bortner CD, Gómez-Angelats M, and Cidlowski JA. Plasma membrane depolarization without repolarization is an early molecular event in anti-Fas-induced apoptosis. J Biol Chem 276: 4304-4314, 2001.
18. + efflux in the activation of apoptosis. J Biol Chem 272: 32436-32442, 1997.
19. Bossy-Wetzel E, Newmeyer DD, and Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17: 37-49, 1998.
20. Boutillier A-L, Trinh E, and Loeffler J-P. Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis. Oncogene 19: 2171-2178, 2000.
21. + inhibit cytochrome c-dependent formation of the apoptosome. J Biol Chem 276: 41985-41990, 2001.
22. Cheng EH-Y, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, and Hardwick JM. Conversion of Bcl-2 to Bax-like death effector by caspases. Science 278: 1966-1968, 1997.
23. Clem RJ, Cheng EH-Y, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, and Hardwick JM. Modulation of cell death by Bcl-xL through caspase interaction. Proc Natl Acad Sci USA 95: 554-559, 1998.
24. Cook SA, Sugden PH, and Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85: 940-949, 1999.
25. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 13: 513-543, 1995.
26. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, and Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6: 698-702, 2000.
27. Cowan KN, Jones PL, and Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105: 21-34, 2000.
28. Cowan KN, Jones PL, and Rabinovitch M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle apoptosis. Circ Res 84: 1223-1233, 1999.
29. Dallaporta B, Hirsch T, Susin SA, Zamzami N, Larochette N, Brenner C, Marzo I, and Kroemer G. Potassium leakage during the apoptotic degradation phase. J Immunol 160: 5605-5615, 1998.
30. Dallaporta B, Marchetti P, de Pablo MA, Maisse C, Duc H-T, Métivier D, Zamzami N, Geuskens M, and Kroemer G. Plasma membrane potential in thymocyte apoptosis. J Immunol 162: 6534-6542, 1999.
31. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, and Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808, 1992.
32. De Caestecker M and Meyrick B. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension. Respir Res 2: 193-197, 2001.
33. Debska G, May R, Kicinska A, Szewczyk A, Elger CE, and Kunz WS. Potassium channel openers depolarize hippocampal mitochondria. Brain Res 892: 42-50, 2001.
34. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, and Knowles JA. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor II-gene. Am J Hum Genet 67: 737-744, 2000.
35. Deveraux QL, Stennicke HR, Salvesen GS, and Reed JC. Endogenous inhibitors of caspases. J Clin Immunol 19: 388-398, 1999.
36. Dispersyn G and Borgers M. Apoptosis in the heart: about programmed cell death and survival. News Physiol Sci 16: 41-47, 2001.
37. Dispersyn G, Nuydens R, Connors R, Borgers M, and Geerts H. Bcl-2 protects against FCCP-induced apoptosis and mitochondrial membrane potential depolarization in PC 12 cells. Biochim Biophys Acta 1428: 357-371, 1999.
38. D'Souza FM, Sparks RL, Chen H, Kadowitz PJ, and Jeter JRJ. Mechanisms of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 284: C191-C199, 2003.
39. Du C, Fang M, Li Y, Li L, and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
40. Durmowicz AG and Stenmark KR. Mechanisms of structure remodeling in chronic pulmonary hypertension. Pediatr Rev 20: e91-e102, 1999.
41. Earnshaw WC, Martins LM, and Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424, 1999.
42. Ekhterae D, Lin Z, Lundberg MS, Crow MT, Brosius FCI, and Núñez G. ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res 85: e70-e77, 1999.
43. + channel activity and enhances survival in vascular smooth muscle cells. Am J Physiol Cell Physiol 281: C157-C165, 2001.
44. + entry. Am J Physiol Cell Physiol 284: C1405-C1410, 2003.
45. + channel mediates regulatory volume decrease response in a human bronchial epithelial cell line. Am J Physiol Lung Cell Mol Physiol 283: L1705-L1714, 2002.
46. Fernández-Salas E, Sagar M, Cheng C, Yuspa SH, and Weinberg WC. p53 and tumor necrosis factor α regulate the expression of a mitochondrial chloride channel protein. J Biol Chem 274: 36488-36497, 1999.
47. Ferri KF and Kroemer G. Mitochondria - the suicide organelles. Bioessays 23: 111-115, 2001.
48. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, and Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946, 1995.
49. Fishman AP. Etiology and pathogenesis of primary pulmonary hypertension. Chest 114: 242S-247S, 1998.
50. Forbes RA, Steenbergen C, and Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88: 802-809, 2001.
51. + current in voltage-clamped CA3 pyramidal cells in hippocampal cultures. Proc Natl Acad Sci USA 82: 1558-1562, 1985.
52. Gao W, Pu Y, Luo KQ, and Chang DC. Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J Cell Sci 114: 2855-2862, 2001.
53. Garlid KD. Cation transport in mitochondria - the potassium cycle. Biochim Biophys Acta 1275: 123-126, 1996.
54. Geraci M, Moore M, Gesell T, Yeager M, Alger L, Golpon H, Gao B, Loyd JE, Tuder RM, and Voelkel NF. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 88: 555-562, 2001.
55. 3H] noradrenaline in rat hippocampal slices. Neuroscience 104: 761-768, 2001.
56. + and cell shrinkage. J Biol Chem 275: 19609-19619, 2000.
57. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res 706: 328-332, 1996.
58. Gottlieb RA and Dosanjh A. Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C27 cells: possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 93: 3587-3591, 1996.
59. Green DR and Evan GI. A matter of life and death. Cancer Cell 1: 19-30, 2002.
60. Green DR and Reed JC. Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
61. Greger R. Membrane voltage and preservation of the ionic distribution across the cell membrane. In: Comprehensive Human Physiology. From Cellular Mechanisms to Integration, edited by Greger R and Windhorst U. Berlin, Heielberg, Germany: Springer-Verlag, 1996, p. 245-266.
62. Gross A, Jockel J, Wei MC, and Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17: 3878-3885, 1998.
63. + channels and myocardial preconditioning. Circ Res 84: 973-979, 1999.
64. Gulbins E, Jekle A, Ferlinz K, Grassmé H, and Lang F. Physiology of apoptosis. Am J Physiol Renal Physiol 279: F605-F615, 2000.
65. He H, Lam M, McCormick TS, and Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 138: 1219-1228, 1997.
66. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T, and Alnemri ES. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 277: 432-438, 2002.
67. Heiskanen KM, Bhat MB, Wang H-W, Ma J, and Nieminen A-L. Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem 274: 5654-5658, 1999.
68. Hengartner MO. The biochemistry of apoptosis. Nature 407: 770-776, 2000.
69. Hockenberry DM, Oltvai ZN, Yin XM, Milliman CL, and Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993.
70. Hodgkin AL. The Conduction of the Nervous Impulse. Liverpool, UK: Liverpool University Press, 1964.
71. + channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol 275: H1567-H1576, 1998.
72. + suppresses the activation of apoptosis in lymphocytes. J Biol Chem 272: 30567-30576, 1997.
73. Hughes FM Jr and Cidlowski JA. Glucocorticoid-induced thymocyte apoptosis: protease-dependent activation of cell shrinkage and DNA fragmentation. J Steroid Biochem Mol Biol 65: 207-217, 1998.
74. Inai Y, Yabuki M, Kanno T, Akiyama J, Yasuda T, and Utsumi K. Valinomycin induces apoptosis of ascites hepatoma cells (AH-130) in relation to mitochondrial membrane potential. Cell Struct Funct 22: 555-563, 1997.
75. + channel in the mitochondrial inner membrane. Nature 352: 244-247, 1991.
76. Jones AW. Content and fluxes of electrolytes. In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am. Physiol. Soc., 1980, sect. 2, vol. II, chapt. 11, p. 253-299.
77. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CYJ, Sasaki T, Elia AJ, Cheng H-YM, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong Y-Y, Mak TW, Zúñiga-Pflücker JC, Kroemer G, and Penninger JM. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554, 2001.
78. Jurgensmeier JM, Xie Z, Deveraux QL, Ellerby L, Bredesen D, and Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95: 4997-5002, 1998.
79. - fluxes to net ion transport by alveolar epithelium. Respir Physiol 85: 245-256, 1991.
80. King LS and Yasui M. Aquaporins and disease: lessons from mice to humans. Trends Endocrinol Metab 13: 355-360, 2002.
81. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD. The release of cytochrome C from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
82. Koch RA and Barish ME. Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. J Neurosci 14: 2585-2593, 1994.
83. Koseki T, Inohara N, Chen S, and Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and hart that interacts selectively with caspase. Proc Natl Acad Sci USA 95: 5156-5160, 1998.
84. Kostyuk PG. Calcium Ions in Nerve Cell Function. Oxford, UK: Oxford University Press, 1992.
85. + channel of heart mitochondria. Am J Physiol Heart Circ Physiol 280: H649-H657, 2001.
86. + currents and mitochondrial membrane depolarization in pulmonary artery myocyte apoptosis. Am J Physiol Lung Cell Mol Physiol 281: L887-L894, 2001.
87. + channels induces apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 280: C970-C979, 2001.
88. + channels in pulmonary vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 282: H184-H193, 2002.
89. Kroemer G and Reed JC. Mitochondrial control of cell death. Nat Med 6: 513-519, 2000.
90. Kulms D and Schwarz T. Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed 16: 195-201, 2000.
91. 2+ fluxes. Proc Natl Acad Sci USA 91: 6569-6273, 1994.
92. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JAI, Loyd JE, Nichols WC, and Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 26: 81-84, 2000.
93. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, Gulbins E, and Häussinger D. Functional significance of cell volume regulatory mechanisms. Physiol Rev 78: 247-306, 1998.
94. Lang F, Lepple-Wienhues A, Paulmichl M, Szabó I, Siemen D, and Gulbins E. Ion channels, cell volume, and apoptotic cell death. Cell Physiol Biochem 8: 285-292. 1998.
95. - conductance in smooth muscle. Am J Physiol Cell Physiol 271: C435-C454, 1996.
96. Lawson CA, Yan SD, Yan SF, Liao H, Zhou YS, Sobel J, Kisiel W, Stern DM, and Pinsky DJ. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 99: 1729-1738, 1997.
97. Lesage F and Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol 279: F793-F801, 2000.
98. Li H, Zhu H, Xu C-J, and Yuan Y. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
99. Liu D, Lu C, Wan R, Auyeung WW, and Mattson MP. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab 22: 431-443, 2002.
100. Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, and Marbán E. Mitochondrial ATP-dependent potassium channels. Viable candidate effectors of ischemic preconditioning, Ann NY Acad Sci 874: 27-37, 1999.
101. Luo X, Budihardjo I, Zou H, Slaughter C, and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998.
102. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JAI, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Dionnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, and Nichols WC. BMPR2 haploinsufficiency as the inherited mechanism for primary pulmonary hypertension. Am J Hum Genet 68: 92-102, 2001.
103. Maeno E, Ishizaki Y, Kanaseki T, Akihiro H, and Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 97: 9487-9492, 2000.
104. Mallat Z and Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 130: 947-962, 2000.
105. Mandegar M, Remillard CV, and Yuan JX-J. Ion channels in pulmonary arterial hypertension. Prog Cardiovasc Dis 45: 81-114, 2002.
106. +-adenosine triphosphatase. Endocrinology 142: 5059-5068, 2001.
107. Massagué J and Chen Y-G. Controlling TGF-β signaling, Genes Dev 14: 627-644, 2000.
108. McDonough AA, Velotta JB, Schwinger RH, Philipson KD, and Farley RA. The cardiac sodium pump: structure and function. Basic Res Cardiol 97: 119-124, 2002.
109. McLaughlin B, Pal S, Tran MP, Parsons AA, Barone FC, Erhardt JA, and Aizenman E. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci 21: 3303-3311, 2001.
110. Meisenholder GW, Martin SJ, Green DR, Nordberg J, Babior GM, and Gottlieb RA. Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection. J Biol Chem 271: 16260-16262, 1996.
111. Michiels C, Arnould T, and Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 1497: 1-10, 2000.
112. Montague JW, Bortner CD, Hughes FMJ, and Cidlowski JA. A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis. Steroids 64: 563-569, 1999.
113. 1 and bone morphogenetic proteins. Circulation 104: 790-795, 2001.
114. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 37: 30-36, 1990.
115. Nelson MT and Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268: C799-C822, 1995.
116. Neuss M, Monticone R, Lundberg MS, Chesley AT, Fleck E, and Crow MT. The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem 276: 33915-33922, 2001.
117. Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JAI, and Loyd JE. Mutation in the gene for bone morphogenetic protein receptor 11 as a cause of primary pulmonary hypertension in large kindred. N Engl J Med 345: 319-324, 2001.
118. Nicholls DG and Budd SL. Mitochondria and neuronal survival. Physiol Rev 80: 315-360, 2000.
119. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 407: 810-816, 2000.
120. Nietsch HH, Roe MW, Fiekers JF, Moore AL, and Lidofsky SD. Activation of potassium and chloride channels by tumor necrosis factor α: role in liver death. J Biol Chem 275: 20556-20561, 2000.
121. O'Donnell ME and Owen NE. Regulation of ion pumps and carriers in vascular smooth muscle. Physiol Rev 74: 683-721, 1994.
122. Oka M, Nagaoka T, Morris KG, and McMurtry IF. Dehydroepiandrosterone markedly reduces the development of hypoxic pulmonary hypertension in rats (Abstract). Am J Respir Crit Care Med 167: A824, 2003.
123. Okada Y and Maeno E. Apoptosis, cell volume regulation and volume-regulatory chloride channels. Comp Biochem Physiol A 130: 377-383, 2001.
124. O'Rourke B. Pathophysiological and protective roles of mitochondrial ion channels. J Physiol 529: 23-36, 2000.
125. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, and Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood Vessels 84: 3392-3400, 1993.
126. + channel from rat liver and beef heart mitochondria. J Biol Chem 267: 26062-26069, 1992.
127. Pitt BR, Weng W, Steve AR, Blakely RD, Reynolds I, and Davies P. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol Lung Cell Mol Physiol 266: L178-L186, 1994.
128. Platoshyn O, Yu Y, Golovina VA, McDaniel SS, Krick S, Li L, Wang JY, Rubin LJ, and Yuan JX-J. Chronic hypoxia decreases Kv channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol 280: L801-L812, 2001.
129. + channels before inducing apoptosis. Am J Physiol Cell Physiol 283: C1298-C1305, 2002.
130. 2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronic hypoxic rats. Circulation 106: II-494, 2001.
131. Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia A-S, and McNamara JO. Electrical signals of nerve cells. In: Neuroscience, edited by Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia A-S, McNamara JO, and Williams SM. Sunderland, MA: Sinauer Associates, 2001, p. 37-50.
132. Rabinovitch M. Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 114: 213S-224S, 1998.
133. Rabinovitch M. Pathobiology of pulmonary hypertension. Extracellular matrix. Clin Chest Med 22: 433-439, 2001.
134. Rabkin SW and Kong JY. Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide. Am J Physiol Heart Circ Physiol 279: H3089-H3100, 2000.
135. Raley-Susman KM, Kass IS, Cottrell JE, Newman RB, Chambers G, and Wang J. Sodium influx blockade and hypoxic damage to CA1 pyramidal neurons in rat hippocampal slices. J Neurophysiol 86: 2715-2726, 2001.
136. - efflux impairment in hematopoietic cell apoptosis. FASEB J 13: 1711-1723, 1999.
137. Reuss L and Hirst BH. Water transport controversies - an overview. J Physiol 542: 1-2, 2002.
138. Riley DJ, Thakker-Varia S, Wilson FJ, Polani GJ, and Tozzi CA. Role of proteolysis and apoptosis in regression of pulmonary vascular remodeling. Physiol Res 49: 577-585, 2000.
139. Rubin LJ and Rich S. Primary Pulmonary Hypertension. New York, NY: Dekker, 1997.
140. Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, and Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11: 1517-1525, 2002.
141. Sasaki N, Sato T, Ohler A, O'Rourke B, and Marbán E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101: 439-445, 2000.
142. Schendel SL, Xie Z, Oblatt Montal M, Matsuyama S, Montal M, and Reed JC. Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 94: 5113-5118, 1997.
143. Schrantz N, Blanchard DA, Auffredou MT, Sharma S, Leca G, and Vazquez A. Role of caspases and possible involvement of retinoblastoma protein during TGFβ-mediated apoptosis of human B lymphocytes. Oncogene 18: 3511-3519, 1999.
144. - ion conductance. J Neurophysiol 51: 500-515, 1984.
145. Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, and Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA 95: 1455-1459, 1998.
146. Shimizu S, Ide T, Yanagida T, and Tsujimoto Y. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem 275: 12321-12325, 2000.
147. Shimizu S, Konishi A, Kodama T, and Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci USA 97: 3100-3105, 2000.
148. 2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem Biophys Res Commun 257: 549-554, 1999.
149. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 423: 275-280, 1998.
150. + current in rat pulmonary artery muscle cells. Am J Physiol Heart Circ Physiol 266: H365-H370, 1994.
151. Stenmark KR and Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89-144, 1997.
152. Strange K, Emma F, and Jackson PS. Cellular and molecular physiology of volume-sensitive anion channels. Am J Physiol Cell Physiol 270: C711-C730, 1996.
153. Strasser A, Harris AW, Huang DC, Krammer PH, and Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 136-147, 1995.
154. Strasser A, O'Connor L, and Dixit VM. Apoptosis signaling. Annu Rev Biochem 69: 217-245, 2000.
155. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, and Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331-1341, 1996.
156. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8: 613-621, 2001.
157. + channel in T lymphocytes upon Fas stimulation. J Biol Chem 271: 20465-20469, 1996.
158. Szabó I, Lepple-Wienhues A, Kaba KN, Zoratti M, Gulbins E, and Lang F. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc Natl Acad Sci USA 95: 6169-6174, 1998.
159. Szewczyk A and Marban E. Mitochondria: a new target for potassium channel openers? Trends Pharmacol Sci 20: 157-161, 1999.
160. +] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. Biochem J 357: 137-145, 2001.
161. Thornberry NA and Lazebnik Y. Caspases: enemies within. Science 281: 1312-1316, 1998.
162. Trimarchi JR, Liu L, Smith PJS, and Keefe DL. Apoptosis recruits two-pore domain potassium channels used for homeostatic volume regulation. Am J Physiol Cell Physiol 282: C588-C594, 2002.
163. L prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Cell 91: 627-637, 1999.
164. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, and Thompson CB. BCL-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637, 1997.
165. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, and Vaux DL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53, 2000.
166. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, and Vaux DL. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454, 2002.
167. Vick RL, Chang DC, Nichols BL, Hazlewood CF, and Harvey MC. Sodium potassium, and water in cardiac tissues. Ann NY Acad Sci 204: 575-592, 1973.
168. Voelkel NF and Tuder RM. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension. Pulm Pharmacol Ther 10: 231-241, 1997.
169. Vu CCQ, Bortner CD, and Cidlowski JA. Differential involvement of
170. + channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62: 4843-4848, 2002.
171. + channel α subunits in pulmonary artery smooth muscle cells. J Clin Invest 100: 2347-2353, 1997.
172. Wang J, Morishima S, and Okada Y. IK channels are involved in the regulatory volume decrease in human epithelial cells. Am J Physiol Cell Physiol 284: C77-C84, 2003.
173. + channel mediates apoptosis of myeloblastic leukemia cells. J Biol Chem 274: 3678-3685, 1999.
174. Wang NS, Unkila MT, Reineks EZ, and Distelhorst CW. Transient expression of wild-type of mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. J Biol Chem 276: 44117-44128, 2001.
175. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
176. Wang X, Xiao Y, Ichinose T, and Yu SP. Effects of tetraethylammonium analogs on apoptosis and membrane currents in cultured cortical neurons. J Pharmacol Exp Ther 295: 524-530, 2000.
177. +-ATPase in cortical neurons. Soc Neurosci Abstr 446.8, 2002.
178. Wesselborg S and Kabelitz D. Activation-driven death of human T cell clones: time course kinetics of the induction of cell shrinkage, DNA fragmentation, and cell death. Cell Immunol 148: 234-241, 1993.
179. + efflux and apoptosis induced by the potassium channel modulatory protein KCAP/PIAS3β in prostate cancer cells. J Biol Chem 27: 17852-17862, 2003.
180. Wolf CM, Reynolds JE, Morana SJ, and Eastman A. The temporal relationship between protein phosphatase, ICE/CED-3 proteases, intracellular acidification, and DNA fragmentation in apoptosis. Exp Cell Res 230: 22-27, 1997.
181. Xiao AY, Wei L, Xia S, Rothman S, and Yu SP. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci 22: 1350-1362, 2002.
182. + channels in the cardiac inner mitochondrial membrane. Science 298: 1029-1033, 2002.
183. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, and Wang X. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
184. Yao Z, Tong J, Tan X, Li C, Shao Z, Kim WC, Venden Hoek TL, Becker LB, Head CA, and Schumacker PT. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol Heart Circ Physiol 277: H2504-H2509, 1999.
185. Yu SP, Canzoniero LMT, and Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol 13: 405-411, 2001.
186. Yu SP and Choi DW. Ions, cell volume, and apoptosis. Proc Natl Acad Sci USA 97: 9360-9362, 2000.
187. + current in ceramide-induced caspase activation and apoptosis in cultured cortical neurons. J Neurochem 73: 933-941, 1999.
188. Yu SP, Yeh C-H, Sensi SL, Gwag BJ, Canzoniero LMT, Farhangrazi ZS, Ying HS, Tian M, Dugan LL, and Choi DW. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 278: 114-117, 1997.
189. Yuan J and Yankner BA. Apoptosis in the nervous system. Nature 407: 802-809, 2000.
190. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 98: 1400-1406, 1998.
191. Yuan JX-J and Rubin LJ. Altered expression and function of Kv channels in primary pulmonary hypertension. In: Potassium Channels in Cardiovascular Biology, edited by Archer SL and Rusch NJ. New York: Kluwer Academic/Plenum, 2001, p. 821-836.
192. Yuan XJ. Role of calcium-activated chloride current in regulating pulmonary vascular tone. Am J Physiol Lung Cell Mol Physiol 272: L959-L968, 1997.
193. Yuan XJ, Goldman WF, Tod ML, Rubin LJ, and Blaustein MP. Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am J Physiol Lung Cell Mol Physiol 264: L116-L123, 1993.
194. + channel gene transcription in primary pulmonary hypertension. Lancet 351: 726-727, 1998.
195. ATP channels and inhibits GABA receptors via protein kinase C-ε in cardiomyocytes. Am J Physiol Heart Circ Physiol 282: H1395-H1403, 2002.
196. Zhang S, Fantozzi I, Krick S, Rubin LJ, and Yuan JX-J. BMP-mediated apoptosis is inhibited in pulmonary artery smooth muscle cells from the patients with primary pulmonary hypertension. Circulation 106: 11-365, 2002.
197. 2+ homeostasis by Bcl-2. J Biol Chem 274: 33267-33273, 1999.